Phaarmasia Limited
BSE: PHRMASI
Prev Close
29.83
Open Price
30.23
Volume
656
Today Low / High
30.23 / 31.32
52 WK Low / High
23.6 / 50.39
Range
29 - 32
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 30.39, reflecting a change of 0.56 (1.8773%). The expected target range on the BSE is 29 - 32. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Phaarmasia Limited Graph
Phaarmasia Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Phaarmasia Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 30.39, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 30.39 | 30.69 | 27.62 - 33.76 |
| 31.00 | 24.80 - 37.20 | ||
| 31.30 | 21.91 - 40.69 | ||
| Bearish Scenario | 30.39 | 30.09 | 27.08 - 33.09 |
| 29.78 | 23.83 - 35.74 | ||
| 29.48 | 20.63 - 38.32 |
Overview of Phaarmasia Limited
ISIN
INE486I01016
Industry
Medical - Pharmaceuticals
Vol.Avg
709
Market Cap
207,471,314
Last Dividend
0
Official Website
IPO Date
2008-05-14
DCF Diff
27.37
DCF
3
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 24.37 Cr | 21.69 Cr | 2.68 Cr | 0.1100 | 0.00 Cr | 0.00 Cr | -2.33 Cr | -1.59 Cr | -2.32 | -1.27 Cr | -0.0652 |
| 2024-03-31 | 30.59 Cr | 26.70 Cr | 3.89 Cr | 0.1271 | 0.00 Cr | 0.16 Cr | -1.16 Cr | -0.52 Cr | -0.76 | -0.16 Cr | -0.0169 |
| 2023-03-31 | 27.49 Cr | 23.20 Cr | 4.29 Cr | 0.1561 | 0.00 Cr | 0.14 Cr | -1.90 Cr | -1.26 Cr | -1.84 | -1.03 Cr | -0.0458 |
| 2022-03-31 | 17.22 Cr | 14.38 Cr | 2.84 Cr | 0.1647 | 0.00 Cr | 0.10 Cr | -2.03 Cr | -1.55 Cr | -2.27 | -1.27 Cr | -0.0899 |
| 2021-03-31 | 19.90 Cr | 14.99 Cr | 4.91 Cr | 0.2468 | 0.00 Cr | 0.17 Cr | -0.40 Cr | 0.31 Cr | 0.46 | 0.83 Cr | 0.0157 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.36 Cr | 21.56 Cr | 12.82 Cr | 8.7359 Cr | 0.01 Cr | -0.35 Cr | 3.06 Cr | 12.29 Cr | 0.00 Cr | 0.00 Cr | 0.06 Cr | 12.6057 Cr |
| 2024-03-31 | 0.49 Cr | 31.45 Cr | 21.15 Cr | 10.2983 Cr | 0.14 Cr | -0.34 Cr | 8.50 Cr | 12.44 Cr | 0.00 Cr | 0.00 Cr | -0.09 Cr | 20.9138 Cr |
| 2023-03-31 | 0.55 Cr | 28.42 Cr | 17.61 Cr | 10.8098 Cr | 0.27 Cr | -0.28 Cr | 6.36 Cr | 12.73 Cr | 0.03 Cr | 0.00 Cr | -0.09 Cr | 17.2845 Cr |
| 2022-03-31 | 0.08 Cr | 21.21 Cr | 9.15 Cr | 12.0592 Cr | 0.03 Cr | -0.06 Cr | 4.24 Cr | 12.73 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 8.8791 Cr |
| 2021-03-31 | 0.26 Cr | 21.91 Cr | 8.26 Cr | 13.6527 Cr | 0.05 Cr | -0.21 Cr | 2.63 Cr | 13.02 Cr | 0.81 Cr | 0.22 Cr | 0.00 Cr | 7.8678 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.0275 Cr | -0.1680 Cr | -0.1293 Cr | -0.1405 Cr | 0.0000 Cr | 0.3642 Cr | -0.1680 Cr | -1.5894 Cr | 0.0000 Cr | 0.0000 Cr | 5.4430 Cr |
| 2024-03-31 | 0.0948 Cr | -0.0326 Cr | -0.1185 Cr | 0.0621 Cr | -0.0565 Cr | 0.6338 Cr | -0.0326 Cr | -0.5182 Cr | -0.0063 Cr | 0.0000 Cr | -2.1448 Cr |
| 2023-03-31 | 0.6499 Cr | -0.0122 Cr | -0.1624 Cr | 0.6241 Cr | 0.4752 Cr | 0.6904 Cr | -0.0258 Cr | -1.4320 Cr | -0.0228 Cr | 0.0000 Cr | -2.1117 Cr |
| 2022-03-31 | -0.1752 Cr | 0.0078 Cr | 0.0001 Cr | -0.1752 Cr | -0.1673 Cr | 0.2152 Cr | 0.0000 Cr | -1.5621 Cr | 0.0001 Cr | 0.0000 Cr | -1.6088 Cr |
| 2021-03-31 | 0.2499 Cr | 0.0000 Cr | -0.0207 Cr | 0.2499 Cr | 0.2292 Cr | 0.3825 Cr | 0.0000 Cr | 0.4787 Cr | -0.0207 Cr | 0.0000 Cr | 3.4498 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.43 Cr | 4.89 Cr | 0.54 Cr | 0.0986 | -0.70 Cr | -0.53 Cr | -0.77 | -0.43 Cr | -0.0967 |
| 2024-12-31 | 4.72 Cr | 3.94 Cr | 0.79 Cr | 0.1664 | -0.88 Cr | -0.70 Cr | -1.02 | -0.60 Cr | -0.1481 |
| 2024-09-30 | 5.93 Cr | 5.60 Cr | 0.32 Cr | 0.0545 | -0.87 Cr | -0.64 Cr | -0.94 | -0.56 Cr | -0.1083 |
| 2024-06-30 | 8.29 Cr | 6.74 Cr | 1.55 Cr | 0.1869 | 0.10 Cr | 0.28 Cr | 0.40 | 0.33 Cr | 0.0333 |
| 2024-03-31 | 9.99 Cr | 8.17 Cr | 1.82 Cr | 0.1826 | 0.25 Cr | 0.48 Cr | 0.69 | 0.53 Cr | 0.0483 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.36 Cr | 0.00 Cr | 0.36 Cr | 3.11 Cr | 3.06 Cr | 8.21 Cr | 12.29 Cr | 21.56 Cr | 12.82 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.38 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -9.93 Cr |
| 2024-09-30 | 0.23 Cr | 0.15 Cr | 0.38 Cr | 7.90 Cr | 4.13 Cr | 13.54 Cr | 12.28 Cr | 26.89 Cr | 16.96 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.63 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -10.30 Cr |
| 2024-03-31 | 0.63 Cr | 0.15 Cr | 0.63 Cr | 8.82 Cr | 8.50 Cr | 17.97 Cr | 12.44 Cr | 31.45 Cr | 21.15 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -0.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -0.56 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.17 Cr | 0.26 Cr | 0.09 Cr | 0.00 Cr | 0.17 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2008-05-14 | May 14, 08 | 1:5 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: female
Year Born:
Gender: male
Year Born: 1963
Gender: male
Year Born:
FAQs about Phaarmasia Limited
The CEO is Yallapragada Naga Bhaskara Rao.
The current price is ₹30.39.
The range is ₹23.6-50.39.
The market capitalization is ₹20.75 crores.
The P/E ratio is -13.11.
The company operates in the Healthcare sector.
Overview of Phaarmasia Limited (ISIN: INE486I01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹20.75 crores and an average daily volume of 709 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.